Company: BLTE
Filing Date: 2025-01-27
Form Type: 424B7
Source: 0001104659-25-006367
Chunk: 0

Company: BELITE BIO, INC
Filing Date: 2025-01-27
Form: 424B7
Chunk 0
---
TABLE OF CONTENTS

#### Filed Pursuant to rule 424(b)(7)​

#### Registration No. 333-284521​

### PROSPECTUS SUPPLEMENT
(to Prospectus dated January 27, 2025)

#### Belite Bio, Inc
<div align='center'>**Up to 651,380 American Depositary Shares representing 651,380 Ordinary Shares**</div>

#### issuable upon exercise of the Warrants
**This prospectus supplement relates to the offer and resale from time to time of our ordinary shares, par value $0.0001 per share, each represented by one American depositary share, or ADS, by the selling shareholder identified in this prospectus supplement (the “selling shareholder”), that may be issued by us to the selling shareholder upon the exercise by such selling shareholder of warrants that were previously issued to such selling shareholder. Throughout this prospectus supplement, we refer to ordinary shares as “offered shares” and warrants issued to such selling shareholder as “Selling Shareholder Warrants” or “Warrants”.

The registration of the offer and resale of the offered shares does not necessarily mean that the selling shareholder will offer or sell such securities. We cannot predict when or in what amounts the selling shareholder may sell any of such securities offered by this prospectus supplement. The offered shares may be sold in one or more transactions at fixed prices, prevailing market prices at the time of sale, prices related to the prevailing market prices, varying prices determined at the time of sale or negotiated prices.

We are not offering for sale any ordinary shares offered by this prospectus supplement. We will receive no proceeds from any sale of ordinary shares by the selling shareholder, but will incur expenses in connection with the registration of these offered shares. See “Selling Shareholder” and “Plan of Distribution.” We are filing this prospectus supplement primarily pursuant to contractual obligations that exist with the selling shareholder.

Our ADSs are listed on the Nasdaq Capital Market, or Nasdaq, under the trading symbol “BLTE.” On January 24, 2025, the last reported sale price of our ADSs on Nasdaq was $59.42 per ADS.

The selling shareholder may offer and resell, at any time and from time to time, the offered shares held by such selling shareholder directly or through underwriters (on a firm commitment basis or best-efforts basis) or agents or broker-dealers on terms to be determined at the time of sale. Such underwriters, agents or broker-dealers may receive